Saudi Scientists Pioneer In Gene Sequencing With NanoRanger Technology

A team of Saudi scientists from King Abdullah University of Science and Technology (KAUST) and King Faisal Specialist Hospital and Research Centre (KFSH&RC) has developed a new gene sequencing system called NanoRanger. This innovative technology promises faster, cheaper, and more accurate identification of genetic mutations responsible for various diseases.

Genetic diseases, especially Mendelian disorders caused by single-gene abnormalities, are prevalent in Saudi Arabia due to high consanguinity rates. Traditional gene sequencing methods have been invaluable but often struggle with complex genetic mutations. NanoRanger addresses this challenge by providing high-resolution DNA analysis, enabling the detection of previously undetectable genetic abnormalities.

According to the KAUST Discovery website, NanoRanger offers a significant improvement over existing methods. "NanoRanger has the potential to transform how we diagnose and treat genetic diseases," said KAUST Associate Professor Mo Li. "By identifying genetic mutations early on, we can provide patients and their families with crucial information to make informed decisions about their healthcare."

The technology has already shown promising results in clinical trials. Researchers successfully identified genetic mutations in 13 patients using NanoRanger. In one notable case, a couple at risk of passing on a genetic disease to their child used the information to plan a healthy pregnancy through in vitro fertilization.

With its potential to significantly improve patient outcomes, KAUST is actively pursuing the commercialization of NanoRanger. The university plans to integrate this technology into standard diagnostic practices across Saudi Arabia.

This breakthrough could revolutionize the diagnosis and treatment of genetic diseases. By offering a more efficient method for identifying genetic mutations, NanoRanger stands to benefit countless patients and their families.

With inputs from SPA